CMT Asset Management’s AbbVie ABBV Stock Holding History

CMT Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,898	Closed	-$524K	–	12
2017 Q3	$524K	Buy	+5,898	New	+$449K	0.03%	144
2016 Q4	–	Sell	-26,730	Closed	-$1.63M	–	179
2016 Q3	$1.69M	Sell	26,730 -9,381	-26%	-$607K	0.08%	139
2016 Q2	$2.24M	Buy	36,111 +24,580	+213%	+$1.5M	0.11%	124
2016 Q1	$659K	Buy	11,531 +7,319	+174%	+$408K	0.04%	159
2015 Q4	$250K	Sell	4,212 -46,849	-92%	-$2.7M	0.01%	185
2015 Q3	$2.78M	Buy	51,061 +33,707	+194%	+$2.19M	0.16%	112
2015 Q2	$1.17M	Sell	17,354 -4,666	-21%	-$305K	0.07%	154
2015 Q1	$1.29M	Buy	+22,020	New	+$1.33M	0.09%	140

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

CMT Asset Management's ABBV Position: Q4 2017 in Review

CMT Asset Management sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 5,898 shares — an estimated $524K sold.

CMT Asset Management first reported a position in ABBV in Q1 2015 and held it in 8 quarters. The position peaked at $2.78M in Q3 2015. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

CMT Asset Management reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
CMT Asset Management sold 5,898 AbbVie shares in Q4 2017, an estimated $524K.
CMT Asset Management first reported a position in AbbVie in Q1 2015 and held it in 8 quarters.
CMT Asset Management's AbbVie position peaked at $2.78M in Q3 2015.
2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on CMT Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.